These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 14649210)

  • 41. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity.
    Masaki T; Yoshimatsu H
    Curr Med Chem; 2010; 17(36):4587-92. PubMed ID: 21062248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.
    Pierson PD; Fettes A; Freichel C; Gatti-McArthur S; Hertel C; Huwyler J; Mohr P; Nakagawa T; Nettekoven M; Plancher JM; Raab S; Richter H; Roche O; Rodríguez Sarmiento RM; Schmitt M; Schuler F; Takahashi T; Taylor S; Ullmer C; Wiegand R
    J Med Chem; 2009 Jul; 52(13):3855-68. PubMed ID: 19456097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histamine and schizophrenia.
    Arrang JM
    Int Rev Neurobiol; 2007; 78():247-87. PubMed ID: 17349864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overview: H3 histamine receptor isoforms: new therapeutic targets in the CNS?
    Chazot PL; Hann V
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1428-31. PubMed ID: 11890359
    [No Abstract]   [Full Text] [Related]  

  • 47. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes.
    Sahlholm K; Nilsson J; Marcellino D; Fuxe K; Arhem P
    Eur J Pharmacol; 2007 Jul; 567(3):206-10. PubMed ID: 17537431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics.
    von Coburg Y; Kottke T; Weizel L; Ligneau X; Stark H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):538-42. PubMed ID: 19091563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
    Mezzomo K; Cumming P; Minuzzi L
    Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Molecular imaging of histamine receptors in the human brain].
    Tashiro M; Yanai K
    Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic benefits of novel histamine H
    Mika K; Szafarz M; Bednarski M; Kuder K; Szczepańska K; Pociecha K; Pomierny B; Kieć-Kononowicz K; Sapa J; Kotańska M
    Biomed Pharmacother; 2021 Oct; 142():111952. PubMed ID: 34325303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in histamine H3 receptor antagonists/inverse agonists.
    Łazewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2010 Sep; 20(9):1147-69. PubMed ID: 20716022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Betahistine inhibits food intake in rats.
    Szelag A; Trocha M; Merwid-Lad A
    Pol J Pharmacol; 2001; 53(6):701-7. PubMed ID: 11985350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
    Nakaya M; Fukushima Y; Takeuchi N; Kaga K
    Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular aspects of the histamine H3 receptor.
    Bongers G; Bakker RA; Leurs R
    Biochem Pharmacol; 2007 Apr; 73(8):1195-204. PubMed ID: 17276412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides.
    Malmlöf K; Golozoubova V; Peschke B; Wulff BS; Refsgaard HH; Johansen PB; Cremers T; Rimvall K
    Obesity (Silver Spring); 2006 Dec; 14(12):2154-62. PubMed ID: 17189541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists.
    Roche O; Nettekoven M; Vifian W; Sarmiento RM
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4377-9. PubMed ID: 18606542
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Keynote review: histamine H3 receptor antagonists reach out for the clinic.
    Celanire S; Wijtmans M; Talaga P; Leurs R; de Esch IJ
    Drug Discov Today; 2005 Dec; 10(23-24):1613-27. PubMed ID: 16376822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histamine H3-receptor inverse agonists as novel antipsychotics.
    Ito C
    Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
    Zaragoza F; Stephensen H; Peschke B; Rimvall K
    J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.